[Use of erythropoiesis stimulating agents].

@article{Lapierre2014UseOE,
  title={[Use of erythropoiesis stimulating agents].},
  author={Ariane Lapierre and Pierre Jean Souquet},
  journal={Revue des maladies respiratoires},
  year={2014},
  volume={31 2},
  pages={162-72}
}
Anemia is fairly common in lung neoplasms and adequate management can influence both the prognosis and the quality of life of patients. Anemia can stem from diverse mechanisms, and its management must include the search for correctable causes (iron deficiency, inflammation, disease- or treatment-related), and their subsequent treatment. Use of erythropoiesis stimulating agents, namely recombinant erythropoietin, results in hemoglobin increase, fewer blood transfusions, and better quality of… CONTINUE READING